Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio: 2016-2025

Historic Interest Coverage Ratio for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Sep 2025 value amounting to -110.46.

  • Rocket Pharmaceuticals' Interest Coverage Ratio rose 25.06% to -110.46 in Q3 2025 from the same period last year, while for Sep 2025 it was -132.46, marking a year-over-year increase of 8.90%. This contributed to the annual value of -144.86 for FY2024, which is 4.60% down from last year.
  • As of Q3 2025, Rocket Pharmaceuticals' Interest Coverage Ratio stood at -110.46, which was up 26.57% from -150.42 recorded in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Interest Coverage Ratio ranged from a high of -22.68 in Q1 2021 and a low of -156.50 during Q2 2024.
  • Its 3-year average for Interest Coverage Ratio is -139.16, with a median of -139.51 in 2023.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first plummeted by 928.35% in 2021, then climbed by 25.06% in 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -95.75 in 2021, then plummeted by 54.49% to -147.93 in 2022, then rose by 8.98% to -134.64 in 2023, then rose by 1.55% to -132.55 in 2024, then increased by 25.06% to -110.46 in 2025.
  • Its last three reported values are -110.46 in Q3 2025, -150.42 for Q2 2025, and -136.42 during Q1 2025.